Colin Hislop's Net Worth

$458 Thousand

Estimate Recalculated Sep 9, 2024 12:20AM EST

Who is Colin Hislop

Colin Hislop does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Versartis, Inc., and Anthera Pharmaceuticals Inc.

SEC CIK

Colin Hislop's CIK is 0001314902

Past Insider Trading and Trends

2017 was Colin Hislop's most active year for acquiring shares with 3 total transactions. Colin Hislop's most active month to acquire stocks was the month of December. 2017 was Colin Hislop's most active year for disposing of shares, totalling 3 transactions. Colin Hislop's most active month to dispose stocks was the month of March. 2017 saw Colin Hislop paying a total of $285,950.00 for 98,200 shares, this is the most they've acquired in one year. In 2017 Colin Hislop cashed out on 70,667 shares for a total of $743,700.85, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Versartis, Inc.

Chief Medical Officer
Updated Oct 23, 2017
Form 4
-2.72%
-667.00
$2.55
-$1.70K
Oct 23, 2017
23.83K
Sale
Oct 19
Form 4
-14.14%
-35.00K
$14.68
-$456.05K
Apr 05, 2017
212.60K
Sale
ScheduledApr 04
Form 4
1,264.00%
63.20K
Jan 31, 2017
68.20K
Grant
Jan 27
Form 4
5.00K
Oct 13, 2016
5.00K
Grant
Oct 11
Form 4
223.10K
May 02, 2016
223.10K
Grant
Apr 04
Form 3
May 02, 2016
Showing 6 results

Anthera Pharmaceuticals Inc

Sr. VP, Cardiovasc. Prod.
Updated Feb 23, 2010
Form 3
Feb 23, 2010
5.84K
Showing 1 results